DISQOVER is a knowledge discovery platform that links siloed data using knowledge graph and semantic technologies, helping life sciences organizations accelerate their drug development activities. Users can search across disparate public and private data sources through a single interface that enables easy and efficient data discovery and exploration. DISQOVER allows researchers and collaborators to swiftly access valuable insights in one place, ensuring that information isn’t overlooked for faster and more accurate decision-making. With DISQOVER, organizations enjoy the benefits of FAIR data, facilitating interoperability, and connectivity with other applications while building a scalable enterprise-linked data ecosystem. Additionally, DISQOVER’s open plug-in architecture allows an organization to seamlessly connect specialized artificial intelligence (AI) services to annotated, standardized, and structured data. DISQOVER is also available with natural language processing (NLP) capabilities ensuring users can maximize the value of their internal unstructured data, along with unstructured public data. Developed specifically for life sciences companies, DISQOVER has over 10,000 users ranging from scientific researchers, bioinformaticians, data scientists, and business profiles. DISQOVER can be deployed to support across the entire drug development life cycle and has four major application areas: R&D, Clinical, Regulatory, and Cross-Functional Intelligence. Customers include AstraZeneca, Amgen, the Princess Máxima Center for Pediatric Oncology, e-therapeutics, among others.